Results 161 to 170 of about 4,157 (182)

Thermal, electromagnetic and structural analysis of gas baffles for the TCV divertor upgrade

Fusion Engineering and Design, 2019
Domenico Marzullo, Pierluigi Fanelli, Giuseppe Calabro   +2 more
exaly  

A scoping study of the application of neutral beam heating on the TCV tokamak

Fusion Engineering and Design, 2011
Basil Duval, Olivier Sauter, Emiliano Fable   +2 more
exaly  

The influence of molecular dynamics on divertor detachment in TCV

Contributions To Plasma Physics, 2004
David Coster, Marco Wischmeier, Roberto Pasqualotto   +2 more
exaly  

Characterization of Hydronephrosis in Neonatal Rats from Dams Receiving Candesartan Cilexetil (TCV-116), an Angiotensin II Type 1 Receptor Antagonist

International Journal of Toxicology, 1999
Yoshimasa Ishimura, Fumio Chatani
exaly  

Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: Possible role of PAF in tissue factor generation

Thrombosis Research, 1993
Z Terashita, Y Imura
exaly  

Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone

European Journal of Pharmacology, 1994
Kohei Nishikawa, M Ojima, Yoshiyuki Inada   +2 more
exaly  

Commissioning of the heating neutral beam injector on the TCV tokamak

Fusion Engineering and Design, 2017
Damien Fasel, Philippe Marmillod, Ugo Siravo   +2 more
exaly  

LTCC magnetic sensors at EPFL and TCV: Lessons learnt for ITER

Fusion Engineering and Design, 2019
Duccio Testa, Thomas Maeder, B Marletaz   +2 more
exaly  

TCV-116: A New Angiotensin II Type-1 Receptor Antagonist

Cardiovascular Drug Reviews, 1994
exaly  

Modeling the initial impact and predicted future benefits of TCV from two Pakistani provinces

The Lancet Regional Health - Southeast Asia
Alicia Kraay, Jillian Gauld
exaly